Innocan Pharma Corporation: Innocan Pharma's Case Report Accepted to the 25M Readers of Frontiers Veterinary Scientific Journal
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 11, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to report the "accepted
Source: finanznachrichten.de